Emphysematous Pyelonephritis Complicating Cystic Renal Tumors: Oncologic outcomes and Management Challenges

O. Bjane*, A. Tmiri, M. El Badr, T. Taïbou ,A.Kbiro,A. Moataz , M. Dakir , A. Debbagh, R. Aboutaieb

Urology department, Ibn rochd hospital, faculty of medicine and pharmacy, Hassan II university, Casablanca, Morocco

*Corresponding author

O. Bjane, Urology department, Ibn rochd hospital, faculty of medicine and pharmacy, Hassan II university, Casablanca, Morocco

Abstract

Introduction: Emphysematous pyelonephritis (EPN) is a severe necrotizing infection characterized by gas formation within the renal parenchyma, typically affecting diabetic or immunocompromised patients. Its association with cystic renal tumors (Bosniak IV) is rare and complicates both diagnosis and management. We present a challenging case of EPN complicating a Bosniak IV cystic renal cell carcinoma, highlighting the interplay between infectious and oncologic priorities.

Case Presentation: A 68-year-old diabetic male presented with sepsis, hematuria, and acute kidney injury. Imaging revealed stage 3b EPN (Huang-Tseng classification) with a 16 cm gas-forming renal abscess and a suspicious Bosniak IV cystic lesion. Initial management with double-J stenting and antibiotics failed, requiring percutaneous drainage (growing E. coli) followed by delayed radical nephrectomy. Histopathology confirmed clear cell renal carcinoma (ISUP 2, pT3a) arising from the cyst. Six-month follow-up showed no recurrence.

Discussion: This case illustrates three key challenges: diagnostic difficulty in distinguishing infection-driven pseudotumoral changes from true malignancy (15-20% of EPN cases involve abnormal kidneys ); (2) therapeutic balance between urgent source control (percutaneous drainage preferred over early nephrectomy) and oncologic principles; and prognostic uncertainty as cystic RCCs show 15-20% 2-year recurrence rates despite radical surgery. The presence of vascular emboli (pT3a) further worsened prognosis.

Conclusion: EPN complicating cystic renal tumors demands multidisciplinary management. A staged approach—drainage, culture-directed antibiotics, then nephrectomy—optimizes outcomes. Long-term surveillance must address both infection resolution and oncologic risk, with consideration of advanced imaging (MRI/PET) to reduce radiation exposure.

Keywords: Emphysematous pyelonephritis; Bosniak IV cyst; Renal cell carcinoma; Percutaneous drainage; Diabetic complications

Introduction

Emphysematous pyelonephritis (EPN) is a rare but life-threatening necrotizing infection characterized by intra- or perirenal gas, primarily occurring in diabetic, immunocompromised, or obstructed urinary tract patients [1,2]. Its association with a suspect renal lesion (Bosniak IV cyst or renal tumor) is exceptionally reported, complicating both diagnosis and management [3,4].

The pathophysiology of EPN typically involves gas-producing pathogens (Escherichia coliKlebsiella pneumoniaeProteus mirabilis), favored by hyperglycemia and diabetic microangiopathy [5]. When a complex renal mass (Bosniak IV) or neoplasm is present, the infection may result from secondary tumor necrosis, fistulization, or tumor-related urinary obstruction [6]. Abdominal CT remains the key imaging modality to identify gas collections, parenchymal destruction extent, and underlying lesion characteristics [7].

We present a case of complicated EPN in a diabetic patient associated with a Bosniak IV mass, highlighting the therapeutic challenges between urgent infection control and oncologic evaluation.

CASE PRESENTATION

We report the case of a 68-year-old male with a history of insulin-dependent type 2 diabetes (14 years) and treated hypertension, admitted for a 5-day sub-occlusive syndrome associated with spontaneous non-clotting macroscopic hematuria. The clinical picture included fever and marked general deterioration (asthenia, anorexia).

On examination, the patient was conscious (GCS 15), afebrile (37.4°C), with right lumbar tenderness but no guarding or bladder distension. Laboratory tests revealed severe inflammation (CRP 251 mg/L, leukocytosis 24,600/mm³), anemia (Hb 7.9 g/dL), and moderate renal insufficiency (serum creatinine 47 mg/L). Abdominal CT showed a pseudo-tumoral right kidney (16 cm) with confluent gas collections (largest: 9.6 × 11.6 cm) and pneumatosis of the calyces, confirming EPN. Three cortical lesions were identified, including an enhancing rounded polar mass (Bosniak IV) and two exophytic mid-renal masses, raising suspicion of an underlying tumor with superimposed infection.

Figure 1: emboli (pT3a) and negative margins. Axial CT scan showing a Bosniak IV cyst located in the upper pole of the right kidney, suspicious for malignancy.

Figure 2: Axial CT scan demonstrating findings consistent with emphysematous pyelonephritis (EPN), with presence of intrarenal and perirenal gas

Figure 3: Surgical specimen showing an encapsulated, fatty mass with central hemorrhagic components, corresponding to the resected lesion

Emergent management included right double-J stent placement under radiological guidance and broad-spectrum IV antibiotics (ceftriaxone + aminoglycoside). Transient hemodynamic stabilization was achieved, but persistent sepsis with chest pain and dyspnea prompted CT pulmonary angiography, revealing a left upper lobar pulmonary embolism extending to segmental branches. The patient was started on LMWH followed by VKAs. A follow-up abdominopelvic CT showed progressive destruction of the right renal parenchyma with a large hydro-air collection (150 × 140 × 190 mm) extending to the posterior pararenal space (56 × 38 mm), hepatic segment VI displacement, and duodenopancreatic complex compression. Additional findings included an anterior pararenal collection (58 × 35 mm), peri-renal fat infiltration, and peri-nephric gas pockets—classified as EPN stage 3b (Huang-Tseng classification) with a Bosniak IV polar cyst.

Despite double-J stenting and appropriate antibiotics, clinical and biological worsening (persistent fever, rising CRP) necessitated percutaneous nephrostomy under CT guidance, draining E. coli (sensitive to imipenem/amikacin). After 3 weeks of targeted antibiotics and drainage, the patient underwent right radical nephrectomy via laparotomy at D28, confirming complete renal destruction with a psoas-abscessing phlegmon but no macroscopic tumor infiltration. Postoperative recovery was uneventful (afebrile, CRP <10 mg/L by D5). Final pathology revealed stage 3b EPN (Huang-Tseng) and clear cell renal carcinoma (ISUP grade 2) arising from a Bosniak IV cyst, with vascular emboli (pT3a) and negative margins.

Follow-up CT at 3 and 6 months post-nephrectomy showed a filled retroperitoneal cavity without residual collections or tumor recurrence.

Discussion

This complex case of emphysematous pyelonephritis (EPN) stage 3b associated with a Bosniak IV cystic renal cell carcinoma presents several critical considerations for the management of severe urological infections in high-risk patients [8]. The diagnostic challenge was particularly significant, as the inflammatory changes from EPN mimicked malignant features on imaging. This diagnostic dilemma is well-documented in recent literature, with studies reporting that 15-20% of EPN cases occur in abnormal kidneys, including 5-7% with underlying malignancies [8]. The limitations of CT imaging in differentiating between infectious and neoplastic processes in such cases have been emphasized [9], highlighting the need for advanced diagnostic approaches. Emerging techniques such as molecular markers (CAIX immunohistochemistry) may improve diagnostic accuracy, though their clinical availability remains limited [17].

The therapeutic strategy employed in this case followed current recommendations for severe EPN management [10]. The three-stage approach of drainage, antibiotic therapy, and delayed nephrectomy has been shown to significantly reduce mortality compared to immediate surgery [10]. Our antibiotic regimen, consisting of imipenem and amikacin for three weeks, was tailored to both the identified pathogen (E. coli) and the extensive tissue involvement, particularly the psoas muscle extension [11]. The partial response to initial percutaneous drainage prior to definitive surgical management supports the findings regarding the importance of adequate infection control before nephrectomy in such complex cases [18].

The unexpected histological diagnosis of clear cell renal cell carcinoma (ISUP grade 2) arising from a Bosniak IV cyst with vascular emboli (pT3a) significantly altered the patient's prognosis and long-term management plan [12]. Current molecular studies demonstrate that cystic renal cell carcinomas frequently harbor VHL mutations that may influence tumor behavior [12]. The presence of vascular emboli, a well-established poor prognostic factor [13], necessitated an intensive surveillance protocol including quarterly CT scans for the first year. The potential impact of the severe preceding infection on tumor biology and metastatic risk remains an area requiring further investigation.

Our follow-up protocol, combining early 3-month imaging to assess infection resolution with standard oncologic surveillance, aligns with current EAU and AUA guidelines [14,15]. The favorable imaging findings at 6 months post-nephrectomy are encouraging, though the known higher recurrence rates of Bosniak IV-derived carcinomas (15-20% at 2 years) [19] warrant continued vigilance. Recent ESUR recommendations [16] suggesting alternating MRI and CT imaging to reduce radiation exposure while maintaining surveillance efficacy may be particularly relevant for such young patients requiring long-term follow-up.

This case highlights several important limitations in current practice. The inability to perform preoperative PET-CT due to the acute septic presentation and lack of molecular tumor profiling represent missed opportunities for more comprehensive characterization of this complex case. Additionally, the relatively short follow-up period prevents assessment of long-term oncologic outcomes. Future management of similar cases might benefit from incorporating advanced imaging techniques and liquid biopsy approaches as they become more widely available.

In conclusion, this case exemplifies the diagnostic and therapeutic challenges posed by EPN complicated by underlying renal neoplasms. It underscores the importance of a multidisciplinary approach combining urological, infectious disease, and oncological expertise. The management strategy must balance urgent infection control with thorough oncologic evaluation, while surveillance protocols need to address both the infectious and neoplastic components of the disease. Continued research into improved diagnostic modalities and personalized treatment approaches for such complex cases remains essential.

References

  1. Huang JJ, Tseng CC (2000)."Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis."Archives of Internal Medicine, 160(6):797-805.
  2. Ubee SS, McGlynn L, Fordham M (2011). "Emphysematous pyelonephritis." BJU International, 107(9):1474-1478.
  3. Craig WD, Wagner BJ, Travis MD (2008)."Pyelonephritis: radiologic-pathologic review."Radiographics, 28(1):255-277.
  4. Grayson DE et al. (2002). "Emphysematous infections of the abdomen and pelvis: a pictorial review." RadioGraphics, 22(3):543-561.
  5. Pontin AR, Barnes RD (2009). "Current management of emphysematous pyelonephritis."Nature Reviews Urology, 6(5):272-279.
  6. Israel GM et al. (2021). "Bosniak Classification of Cystic Renal Masses: Version 2019."Radiology, 292(2):475-488.
  7. Chen MT et al.(2017). "Emphysematous pyelonephritis with renal cell carcinoma: a case report and literature review." Urological Science, 28(4):238-241.
  8. Chen YT et al. (2019) "Emphysematous pyelonephritis in renal anomalies: A 15-year retrospective study with emphasis on tumor mimics". Urology. 2019;134:45-49.
  9. Grayson DE et al. (2021) "CT pitfalls in differentiating complex renal infections from malignancies". American Journal of Roentgenology. 2021;217(2):345-352
  10. Zhang X et al. (2023) "Staged versus immediate nephrectomy for emphysematous pyelonephritis: A meta-analysis of 482 cases". European Urology Focus. 2023;9:456-463.
  11. IDSA Guidelines (2022) "Complicated urinary tract infections: Executive summary". Clinical Infectious Diseases. 2022;74(1):89-104.
  12. Moch H et al. (2022) WHO Classification of Tumours: Urinary and Male Genital Tumours. 5th ed. Lyon: IARC Press; 2022.
  13. Ljungberg B et al. (2023) "EAU guidelines on renal cell carcinoma: 2023 update". European Urology. 2023;83(5):422-432.
  14. Bonkat G et al. (2023) "EAU guidelines on urological infections". European Urology. 2023;83:71-88.
  15. Campbell SC et al. (2023) "AUA guideline on renal mass and localized renal cancer: 2023 update". Journal of Urology. 2023;210(1S):e1-e15.
  16. Scialpi M et al. (2023) "ESUR guidelines on follow-up of treated renal cancer: 2023 update". European Radiology. 2023;33(5):3172-3184.
  17. Gupta S, Johnson SH, Vasmatzis G, et al (2021). "Molecular signatures of cystic renal cell carcinoma in emphysematous pyelonephritis: a diagnostic paradigm shift" Modern Pathology;34(1):78-85.
  18. Huang JJ, Tsai SH, Lin AT, et al (2022). "Optimal drainage strategy for emphysematous pyelonephritis: A multicenter propensity-score analysis" The Journal of Urology;207(1):23-31.
  19. Gorin MA, Patel HD, Rowe SP, et al (2022). "Oncologic Outcomes of Cystic Renal Cell Carcinoma: A SEER Database Analysis" The Journal of Urology;208(4):789-797.
TOP